Quebec’s Favourite Convenience Store Operator Just Got a Floor Price

Metro, Inc. (TSX:MRU) just sold most of its remaining stake in Alimentation Couche Tard Inc. (TSX:ATD.B), giving the convenience store operator’s shareholders a warm, fuzzy feeling. Here’s why.

| More on:

It’s probably the worst-kept secret so far in 2017.

Metro, Inc. (TSX:MRU) announced October 12 that it was selling 85% of its 32 million shares in Alimentation Couche Tard Inc. (TSX:ATD.B) to fund its $4.5 billion acquisition of Jean Coutu Group PJC Inc. (TSX:PJC.A).

When Metro announced the deal to buy the Quebec drug store October 2, I immediately speculated that the four founding shareholders, including executive chairman Alain Bouchard, would buy the Metro stake to further their hold on the world’s second-largest convenience store operator.

My rationale was that Metro helped Couche Tard in the early stages of its growth; it was now time for the company to return the favour. It did, but not exactly as I thought it would.

Couche Tard gets a new crew of shareholders

Metro needed cash for its acquisition, so it was clear from the outset that it would look for a buyer; it found three.

In the first transaction, Metro sold 11.37 million Class B shares (one vote per share) to a couple of investment dealers in a bought deal arrangement for $57.17 per share. That brought in $650 million. The second deal saw it sell 11.37 million Class A shares (10 votes per share) to Caisse de dépôt et placement du Québec, the Quebec pension fund, also for $57.17 per share and proceeds of $650 million. Finally, the third deal saw Couche Tard (not Bouchard or the three other founders) repurchase 4.37 million Class B shares for cancellation, also at $57.17 per share.

So, Couche Tard trades Metro for the Caisse and whomever the investment dealers can get to buy the shares above $57.17 a share.

Several things to note about these transactions

First, and most importantly, is the fact these transactions establish an artificial floor price of $57.17, which should give Couche Tard shareholders a warm fuzzy feeling. That’s because the Caisse is all about delivering returns for Quebec shareholders. It’s not about to buy any Couche Tard shares for $57.17 if it doesn’t feel they’re worth more than that.

As I write this, Couche Tard shares have closed October 12 trading at $61.24 — 7.1% higher than what all three buyers paid for their shares, which brings me brings me to my next point about the transactions.   

Although Bouchard and the rest of the founders didn’t buy any of the shares Metro put up for sale, the company repurchased 4.7 million shares, which lowers the total number outstanding, increasing the founder’s grip on the company if ever so slightly.

Normally, I’m not a big fan of share repurchases, because they’re often done at inflated prices, but given its history with Metro, it really had no choice but to take some of the action. The buyback is a case of win/win.

Metro makes tactical error

Lastly, and this is directed to Metro shareholders, your company just paid a significant price to get a deal done, because when it announced the acquisition, the shares were worth $1.84 billion; it sold them for $1.55 billion — $290 million less for a 16% haircut. It could have borrowed the $1.55 billion for much less while holding on to a valuable asset.

Metro sold part of its stake in Couche Tard back in January 2013 to three banks for $47.90 per share ($15.97 per share adjusting for three-for-one stock split). In hindsight, it shouldn’t have done that. Given the terms of the latest deal, I don’t think it should have sold at this point, either.

Metro had 15 million Class A shares in July 2012 and 5.7 million Class B shares. Today, if it kept all of them, it would have 45 million Class A shares and 17.1 million Class B shares worth $3.8 billion.

So, not only did it get $290 million less than the going rate for selling the 27.1 million shares, it also lost $1.8 billion by selling in 2013.

This is a big win for Couche Tard.

For Metro, it’d better hope the integration of Jean Coutu goes well, or this could turn out to be one of the worst M&A deals in Canadian history.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned. Alimentation Couche Tard is a recommendation of Stock Advisor Canada.

More on Investing

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold Forever

Here are 2 TFSA-worthy Canadian stocks. Which one is a good buy for your TFSA today?

Read more »

Canada day banner background design of flag
Investing

Got $500? 5 Top Canadian Stocks to Buy and Hold

These top Canadian stocks have solid fundamentals with potential to outperform the benchmark index by a wide margin.

Read more »

man touches brain to show a good idea
Energy Stocks

1 No-Brainer Energy Stock to Buy With $500 Right Now

Should you buy a cyclical energy stock at its decade-high? Probably not. But read this before you make a decision.

Read more »

Asset Management
Stocks for Beginners

TFSA: 4 Canadian Stocks to Buy and Hold Forever

Thinking about what to buy with the new TFSA contribution space in 2025? These four Canadian stocks are worth holding…

Read more »